In March 2025, the company declared new designs for the direct-to-customer supplying of its Wegovy weight loss drug. The company proven a completely new pharmacy, termed NovoCare, which might charge shoppers $499 monthly for access to the drug, less than 50 percent the cost of the drug by other pharmaceutical distribution networks.[53]Incorporate t